ArticleProceedings of the National Academy of Sciences of the United States of America2022

H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.

Mehdi Baratchian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.